/Companies

Curesponse

2 known investors

Find your way into Curesponse

Sign up to see every warm intro you have to Curesponse

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Curesponse team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts. The company operates laboratories in the UK and Israel to support oncology treatment decisions.

Founders & leadership

GNGuy Neev
Guy NeevCo-Founder & CEOCo-founder and CEO of Curesponse, which applies science and technology to support oncology treatment decisions through laboratories in the UK and Israel.
DRDr. Ravid Straussman
Dr. Ravid StraussmanScientific Founder
DSDr. Seth Salpeter
Dr. Seth SalpeterCo-Founder & CTO
EDEran Dor
Eran DorCFO

Investors · 2

Funding

SEC filings, press & company announcements

$6M disclosed across 1 of 3 rounds · 2020–2021

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Curesponse do?
Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts. The company operates laboratories in the UK and Israel to support oncology treatment decisions.
Who founded Curesponse?
Curesponse was founded by Guy Neev, Dr. Ravid Straussman, Dr. Seth Salpeter.
Who are Curesponse's investors?
Curesponse's investors include NCL Technology Ventures Ltd., aMoon.
How much funding has Curesponse raised?
Curesponse has disclosed $6M raised across 1 of its 3 known rounds.